Generic and Biosimilar Drugs

In this episode, Jeremy Schmerer and Ryan LaRanger discuss generic and biosimilar drugs in the context of what they are, how they come to exist, patents, and future opportunities.

You can listen to all Truncated Thoughts episodes here, and also at Apple, Spotify, and Stitcher.

If you have any questions or would like to know if we can help your business with its innovation challenges, please leave your info here or contact Jeremy Schmerer, Healthcare & Life Sciences Lead, directly at [email protected].